Cobalt chloride enhances angiogenic potential of CD133 + cells

Tao Zan,Zijing Du,Hua Li,Qingfeng Li,Bin Gu
DOI: https://doi.org/10.2741/4048
IF: 3.1
2012-01-01
Frontiers in Bioscience-Landmark
Abstract:Umbilical cord blood-derived CD133(+) cells differentiate into endothelial cells and induce new blood vessel growth. Hypoxia-inducible factor-1 (HIF-1), a regulator of hypoxia or hypoxia-mimetic agent, activates the SDF-1/CXCR4 signaling pathway and plays an important role in angiogenesis in vivo. In this study, we determined whether CD133(+) cells enhance angiogenic potential through hypoxia or hypoxia mimetic agent (CoCl2) in vitro. The CD133(+) cells were cultured respectively, in normoxia (20% O-2), or hypoxia (10% O-2, 3% O-2), or with various concentrations of CoCl2 (50 microM/L, 100 microM/L, 200 microM/L). We showed here that both hypoxia and CoCl2 induced hypoxia cause a significant increase of CD133(+) cell migration, proliferation, and tubule-like structure formation. Under conditions of hypoxia or CoCl2 induced hypoxia, the HIF-1 alpha, SDF-1, and VEGF protein and gene expression level are elevated as compared to those under normoxia conditions. These data suggest that a hypoxia mimetic agent can be used to enhance the angiogenic potential of CD133(+) cells.
What problem does this paper attempt to address?